Long-acting injectable CAB/RPV_SUPLA W24

Data from the SUPLA trial up to Week 24, with extended follow-up data available for a subset of participants. This dataset includes the following components: Study group assignment for each participant (gric) Longitudinal CD4 cell counts (cd4) and HIV-1 RNA levels (vir) collected during the trial Baseline resistance-associated mutations (resi) Depression (depr) and HIV self-stigma (stig) scores HIV diagnosis date, most recent HIV-1 RNA level, and CD4 count collected during eligibility screening (diag) Participant demographic and baseline clinical characteristics, including age, sex at birth, height, weight, and underlying comorbidities (dm) A list of participants excluded after randomization and the corresponding reasons for exclusion (OFF) Important note: Due to limitations of the electronic record system used in this study, the variable “visit” represents the page number of the electronic case report form rather than the actual visit number. Specifically, “Visit 2” corresponds to “Page 2” and contains the Day 1 records.本数据集涵盖SUPLA试验截至第24周的研究数据，且为部分受试者提供了延长随访的补充数据。 本数据集包含以下组成部分： 1. 每位受试者的研究分组分配信息（gric） 2. 试验期间采集的纵向CD4细胞计数（cd4）与HIV-1 RNA载量（vir） 3. 基线耐药相关突变信息（resi） 4. 抑郁（depr）与HIV病耻感（stig）评分 5. 受试者资格筛查阶段采集的HIV诊断日期、最新HIV-1 RNA载量及CD4细胞计数（diag） 6. 受试者人口学特征与基线临床特征，包括年龄、出生性别、身高、体重及基础合并症（dm） 7. 随机化后被排除的受试者名单及对应的排除原因（OFF） 重要提示：受本研究所用电子病历系统的限制，变量"visit"的取值代表电子病例报告表的页码，而非实际访视编号。具体而言，当变量"visit"取值为"Visit 2"时，对应"第2页"，其中包含第1天的研究记录。